Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
Crossref DOI link: https://doi.org/10.1007/s13300-021-01170-3
Published Online: 2021-10-26
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Popovic, Djordje S.
Papanas, Nikolaos
Pantea Stoian, Anca
Rizvi, Ali A.
Janez, Andrej
Rizzo, Manfredi
Text and Data Mining valid from 2021-10-26
Version of Record valid from 2021-10-26
Article History
Received: 9 August 2021
Accepted: 5 October 2021
First Online: 26 October 2021